El 15 de febrero de 1960 la <<Food and Drug Administration>> (FDA) aprobo en los Estados Unidos de America el uso del Enovid
como anticonceptivo, y desde ese momento su empleo se extendio por todo el mundo, planteando numerosos interrogantes a la teologia moral (poco antes, y con el nombre de Enavid, se habia comercializado en Inglaterra).
In 1960, in the United States, the Food and Drugs Agency (FDA) authorized the commercialization of the first contraceptive pill, Enovid
, produced by Searle.
, dreamt up by a woman, Margaret Sanger, and funded by another, Katherine McCormick, was marketed as medication to regulate periods, but it had a welcome side-effect.
The first OC, the Enovid
pill, had been previously approved for sale for the purpose of regulating periods.
The extremely understaffed FDA assigned the Enovid
application to a young obstetrician-gynecologist who worked for the agency part-time while completing his medical residency.
In 1960, the Food and Drug Administration approved a combination estrogen-progestin pill called Enovid
as an oral contraceptive.
The menstrual cycle: A double-blind study of symptoms, mood and behavior, and biochemical variables using Enovid
En mayo de 1960, la Food and Drug Administration (FDA) aprobo su comercializacion bajo el nombre de Enovid
In benign lesion, the endometrium of patient receiving Enovid
(combined contraceptive pills) and clomiphene citrate for contraception are the possible cause of calcification.
, the first oral contraceptive, was initially introduced for the regulation of menses in 1957.
A further step forward was introduced when--starting from the same observation of beneficial effects of pregnancy on endometriosis--the first oral contraceptive ever marketed, Enovid
(norethinodrel plus mestranol) was administered to 23 women with endometriosis.
True, they were effective--yielding a reliable pattern of uterine withdrawal bleeding--but those high, high-dose estrogen formulations, such as Enovid
, also carried an excessive rate of deep venous thrombosis (DVT) and pulmonary embolism (PE).